Multitargeted inhibition of hepatic fibrosis in chronic iron-overloaded mice by Salvia miltiorrhiza
- PMID: 23707206
- DOI: 10.1016/j.jep.2013.05.028
Multitargeted inhibition of hepatic fibrosis in chronic iron-overloaded mice by Salvia miltiorrhiza
Abstract
Ethnopharmacological relevance: Salvia miltiorrhiza (SM, also known as Danshen) is a well-known Chinese medicinal herb, which has shown hepatoprotective effects with anti-fibrotic, anti-oxidative, anti-inflammatory and anti-apoptotic properties. To explore the effects and potential mechanism of SM against hepatic fibrosis induced by chronic iron overload in mice.
Materials and methods: Sixty male mice were randomized into five groups (n=12 in each group): control (saline), iron overload, iron overload with low-dose SM (3g/kg/day), iron overload with high-dose SM (6g/kg/day) and iron overload with deferoxamine (100mg/kg/day) groups. The iron overload model was established by intraperitoneal injection with iron dextran at 50mg/kg body weight/day, and the entire course lasted for 7 weeks. The major constituents of SM injection were quantified by high performance liquid chromatography. Changes of hepatic iron, hydroxyproline (Hyp), glutathione (GSH), superoxide dismutase (SOD) and malondialdehyde (MDA) were assayed by standard procedures. Protein expression levels of type I collagen, type III collagen, tumor necrosis factor-α (TNF-α) and interleukin-1α (IL-1α) were analyzed by immunohistochemistry, and mRNA levels of transforming growth factor-β (TGF-β), matrix metal proteinase-9 (MMP-9) and caspase-3 were detected by RT-PCR. Morphological changes were observed with Prussian blue, Masson's trichrome and hematoxylin-eosin staining.
Results: Treatment of chronic iron-overloaded mice with SM dose-dependently ameliorated changes in hepatic morphology and coefficient, reduced iron deposition and Hyp content, suppressed overexpression of type I collagen and type III collagen, downregulated expression of TGF-β mRNA, and upregulated expression of MMP-9 mRNA in the liver. Moreover, SM treatment contributed to decreased MDA content, increased SOD activity and GSH content, while it reduced expression of TNF-α, IL-1α and caspase-3.
Conclusions: SM displayed anti-fibrotic activity in the liver induced by chronic iron overload, which may be attributed to multitargeted inhibition of iron deposition and collagen accumulation, as well as oxidative stress, inflammation and apoptosis.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Continuing treatment with Salvia miltiorrhiza injection attenuates myocardial fibrosis in chronic iron-overloaded mice.PLoS One. 2015 Apr 7;10(4):e0124061. doi: 10.1371/journal.pone.0124061. eCollection 2015. PLoS One. 2015. PMID: 25850001 Free PMC article.
-
Mechanism of protective effects of Danshen against iron overload-induced injury in mice.J Ethnopharmacol. 2013 Jan 9;145(1):254-60. doi: 10.1016/j.jep.2012.10.060. Epub 2012 Nov 10. J Ethnopharmacol. 2013. PMID: 23147497
-
Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-beta1 downregulation.Eur Rev Med Pharmacol Sci. 2012 Oct;16(11):1484-98. Eur Rev Med Pharmacol Sci. 2012. PMID: 23111960
-
Oxidative Stress and Salvia miltiorrhiza in Aging-Associated Cardiovascular Diseases.Oxid Med Cell Longev. 2016;2016:4797102. doi: 10.1155/2016/4797102. Epub 2016 Oct 11. Oxid Med Cell Longev. 2016. PMID: 27807472 Free PMC article. Review.
-
Salvia miltiorrhiza in diabetes: A review of its pharmacology, phytochemistry, and safety.Phytomedicine. 2019 May;58:152871. doi: 10.1016/j.phymed.2019.152871. Epub 2019 Feb 18. Phytomedicine. 2019. PMID: 30851580 Review.
Cited by
-
Anti-fibro-hepatocarcinogenic Chinese herbal medicines: A mechanistic overview.J Intercult Ethnopharmacol. 2016 Jun 14;5(3):278-89. doi: 10.5455/jice.20160530032814. eCollection 2016 Jun-Aug. J Intercult Ethnopharmacol. 2016. PMID: 27366355 Free PMC article. Review.
-
Synergistic Differential DNA Demethylation Activity of Danshensu (Salvia miltiorrhiza) Associated with Different Probiotics in Nonalcoholic Fatty Liver Disease.Biomedicines. 2024 Jan 25;12(2):279. doi: 10.3390/biomedicines12020279. Biomedicines. 2024. PMID: 38397881 Free PMC article.
-
Progress on traditional Chinese medicine in improving hepatic fibrosis through inhibiting oxidative stress.World J Hepatol. 2023 Oct 27;15(10):1091-1108. doi: 10.4254/wjh.v15.i10.1091. World J Hepatol. 2023. PMID: 37970620 Free PMC article. Review.
-
Inhibition of Tanshinone IIA, salvianolic acid A and salvianolic acid B on Areca nut extract-induced oral submucous fibrosis in vitro.Molecules. 2015 Apr 15;20(4):6794-807. doi: 10.3390/molecules20046794. Molecules. 2015. PMID: 25884554 Free PMC article.
-
Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects.Int J Mol Sci. 2015 Dec 2;16(12):28705-45. doi: 10.3390/ijms161226126. Int J Mol Sci. 2015. PMID: 26633388 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous